In addition, the bispecific antibodies redirecting the T cells towards the antigen-presenting cells and augmenting their activation by enhancing the B7/CD28 co-stimulation, may allow for establishing a more durable anti-cancer immune response [9]. This evidence concerns the gene CD28 and cancer.